Key Points
- The CFTC filed a motion requesting dismissal of CME Group’s legal challenge to the approval of cryptocurrency perpetual futures contracts.
- Federal regulators contend that CME has failed to demonstrate concrete financial harm, undermining its legal standing in the case.
- The CFTC noted that CME Group maintains the option to launch comparable perpetual futures products using the identical regulatory pathway.
- CME Group contends that Kalshi’s Bitcoin perpetual offerings should fall under swap regulations instead of futures classification.
- Regulators assert that even a favorable court decision for CME would fail to eliminate competitive pressure, as Kalshi could offer equivalent products under swap classification.
The U.S. Commodity Futures Trading Commission (CFTC) has submitted a formal request to a federal court seeking dismissal of CME Group’s legal action challenging the regulator’s approval of crypto perpetual futures products. The commission maintains that CME Group has failed to establish concrete harm stemming from this regulatory decision, thereby undermining its standing to pursue litigation.
Regulators Question Exchange’s Legal Foundation
In documents submitted on September 2, the CFTC characterized the legal dispute as overblown, stating CME has failed to articulate specific financial damages connected to the regulatory approval granted to Kalshi for its Bitcoin perpetual futures contract.
The commission emphasized that CME Group possesses the authority to introduce comparable financial instruments through identical regulatory channels. The regulator pointed to CME’s own statements indicating its clients have shown minimal interest in perpetual futures products, suggesting that any competitive disadvantage stems from CME’s strategic business decisions rather than regulatory action.
Commission Argues Judicial Intervention Offers No Relief
The CFTC maintained that CME Group cannot demonstrate how a favorable court classified outcome would remedy its alleged competitive injury. The filing explains that reclassifying these instruments as swaps would simply enable Kalshi and other approved trading venues to provide equivalent products under alternative regulatory categories.
Regulators further contended that variations in taxation, reporting requirements, or recordkeeping obligations would fail to eliminate market competition. The agency referenced the Commodity Exchange Act, asserting the statute provides no protection shielding one exchange from competitive product launches or strategic decisions made by rival platforms.
CME Group Challenges Product Category Determination
CME Group initiated the lawsuit in June following the CFTC’s authorization of Kalshi’s BTCPERP contract as a futures instrument. The product mirrors Bitcoin’s spot market price, operates around the clock, carries no settlement deadline, and employs funding rate mechanisms between parties holding long and short positions. Regulatory approval came within 24 hours of Kalshi’s submission.
CME Group asserts these operational characteristics align with statutory definitions for swaps rather than futures contracts. The exchange further challenges the CFTC’s justification, questioning why the current position contradicts previous enforcement actions targeting similar crypto perpetual instruments. Kalshi launched Bitcoin perpetual trading on June 3, followed by Ethereum perpetuals the following day.
Federal Court Requires Document Production to Proceed
U.S. District Judge Colleen Kollar-Kotelly recently denied the CFTC’s motion to postpone delivery of the administrative record. The judge determined that this documentation may include relevant evidence pertaining to CME’s assertions of competitive harm.
The court directed both parties to submit a unified briefing timeline by September 4. The litigation now focuses on whether CME Group can successfully demonstrate legal standing before the court addresses the fundamental question of how American law should categorize crypto perpetual contracts.





